Correlation Between Tumor Vasculogenic Mimicry and Poor Prognosis of Human Digestive Cancer Patients: A Systematic Review and Meta-Analysis

Pathology oncology research: POR

article

Ren, Hong-Yue¹  Shen, Jin-Xing²  Mao, Xiao-Mei²  Zhang, Xiao-Yun²  Zhou, Pan²  Li, Si-Yang²  Zheng, Zhi-Wei²  Shen, Dong-Yan²  Meng, Jia-Rong¹ 

[1] Department of Pathology, The Affiliated Southeast Hospital of Xiamen University;The First Affiliated Hospital of Xiamen University

关键词: Vasculogenic mimicry;    digestive cancer;    prognosis;    meta-analysis;   

DOI  :  10.1007/s12253-018-0496-3

来源: Springer

【 摘 要 】

Vasculogenic mimicry (VM) is a new pattern of blood supplement independent of endothelial vessels, which is related with tumor invasion, metastasis and prognosis. However, the role of VM in the prognosis of cancer patients is controversial. This study aimed to perform a meta-analysis of the published data to attempt to clarify the prognostic value of VM in the digestive cancer. Relevant studies were retrieved from the PubMed, Web of Science, Cochrane Library, Chinese National Knowledge Infrastructure and VIP databases published before March 29, 2018. Studies were included if they detected VM in the digestive cancer and analyzed the overall survival (OS) or disease-free survival (DFS) according to VM status. Two independent reviewers screened the studies, extracted data, and evaluated the quality of included studies with the Newcastle-Ottawa scale. Meta-analysis was performed using STATA 12.0 software. A total of 22 studies with 2411 patients were included in this meta-analysis. Meta-analysis showed that VM was related with the poor OS (HR = 2.30, 95% CI: 2.06–2.56, P < 0.001) and DFS (HR = 2.60, 95% CI: 2.07–3.27, P < 0.001) of patients with digestive cancer. Subgroup analysis showed VM was related with tumor differentiation, lymph node metastasis and TNM stage. Moreover, the present meta-analysis was reliable, and there was no obvious publication bias. This meta-analysis suggested that VM was a poor prognosis of digestive cancer patients. Further large and well-designed studies are required.

【 授权许可】

Unknown